Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

Saved in:
Bibliographic Details
Main Authors: San-Miguel, Jesús F. (Author) , Goldschmidt, Hartmut (Author)
Format: Article (Journal)
Language:English
Published: October 2015
In: Haematologica
Year: 2015, Volume: 100, Issue: 10, Pages: 1334-1339
ISSN:1592-8721
DOI:10.3324/haematol.2015.125864
Online Access:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2015.125864
Get full text
Author Notes:Jesus F. San Miguel, Katja C. Weisel, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michele Cavo, Valentina Ivanova, Adrian Alegre, Joaquin Martinez-Lopez, Christine Chen, Christoph Renner, Nizar Jacques Bahlis, Xin Yu, Terri Teasdale, Lars Sternas, Christian Jacques, Mohamed H. Zaki, and Meletios A. Dimopoulos

MARC

LEADER 00000caa a2200000 c 4500
001 1549487442
003 DE-627
005 20220813081746.0
007 cr uuu---uuuuu
008 161108s2015 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2015.125864  |2 doi 
035 |a (DE-627)1549487442 
035 |a (DE-576)479487448 
035 |a (DE-599)BSZ479487448 
035 |a (OCoLC)1340933516 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a San-Miguel, Jesús F.  |e VerfasserIn  |0 (DE-588)143455028  |0 (DE-627)70449468X  |0 (DE-576)337160635  |4 aut 
245 1 0 |a Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma  |c Jesus F. San Miguel, Katja C. Weisel, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michele Cavo, Valentina Ivanova, Adrian Alegre, Joaquin Martinez-Lopez, Christine Chen, Christoph Renner, Nizar Jacques Bahlis, Xin Yu, Terri Teasdale, Lars Sternas, Christian Jacques, Mohamed H. Zaki, and Meletios A. Dimopoulos 
264 1 |c October 2015 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.11.2016 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 100(2015), 10, Seite 1334-1339  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma 
773 1 8 |g volume:100  |g year:2015  |g number:10  |g pages:1334-1339  |g extent:6  |a Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma 
856 4 0 |u http://dx.doi.org/10.3324/haematol.2015.125864  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20161108 
993 |a Article 
994 |a 2015 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1549487442  |e 2944102206 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1549487442"],"doi":["10.3324/haematol.2015.125864"]},"physDesc":[{"extent":"6 S."}],"name":{"displayForm":["Jesus F. San Miguel, Katja C. Weisel, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michele Cavo, Valentina Ivanova, Adrian Alegre, Joaquin Martinez-Lopez, Christine Chen, Christoph Renner, Nizar Jacques Bahlis, Xin Yu, Terri Teasdale, Lars Sternas, Christian Jacques, Mohamed H. Zaki, and Meletios A. Dimopoulos"]},"relHost":[{"recId":"814204899","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1592-8721"],"zdb":["2805244-4"],"eki":["814204899"]},"title":[{"title_sort":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica"}],"pubHistory":["99.2014 -"],"note":["Gesehen am 27.05.2022"],"origin":[{"dateIssuedKey":"2014","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-","publisherPlace":"Pavia"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myelomaHaematologica","language":["eng"],"part":{"volume":"100","extent":"6","text":"100(2015), 10, Seite 1334-1339","issue":"10","year":"2015","pages":"1334-1339"},"titleAlt":[{"title":"journal of the European Hematology Association"}]}],"recId":"1549487442","type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma","title_sort":"Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma"}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"October 2015"}],"note":["Gesehen am 08.11.2016"],"language":["eng"],"person":[{"family":"San-Miguel","display":"San-Miguel, Jesús F.","role":"aut","given":"Jesús F."},{"family":"Goldschmidt","display":"Goldschmidt, Hartmut","given":"Hartmut","role":"aut"}]} 
SRT |a SANMIGUELJIMPACTOFPR2015